Zdrowie i gospodarka · 1.09.1999
Use of Ozone-Depleting Substances; Essential Use Determinations
The Food and Drug Administration (FDA) is proposing to amend its regulation on the use of chlorofluorocarbon (CFC) propellants in self-pressurized containers to make it consistent with other laws. FDA is proposing to set the standard it will use to determine when the use of an ozone-depleting substance (ODS) in a product regulated by FDA is essential under the Clean Air Act. Under the Clean Air Act, FDA, in consultation with the Environmental Protection Agency (EPA), is required to determine whether the use of an ODS in an FDA-regulated product is essential. FDA is also proposing in this rule to remove current essential-use designations for products no longer marketed and for metered-dose steroid human drugs for nasal inhalation. FDA would add or remove specific essential use designations for other products by engaging in separate notice-and-comment rulemaking.